Neeraj Adya
Immunology & Diagnostic Development Leader Johnson & Johnson
Seminars
Wednesday 1st April 2026
Translating Biomarkers into Clinical Strategy: Lessons from Other Immunological Diseases for IBD
12:30 pm
- Discuss Precision Medicine opportunities for in IBD using predictive and prognostic biomarkers, drawing parallels with immunology and Oncology programs advancing into later trials
- Unpack the gap between translational biomarker insights and real-world diagnostics, including regulatory, commercial, and scalability hurdlesDiscuss challenges in moving from translation level biomarker insights to clinically validated tools
